Accordingly, dysregulation of HIRA or DAXX complexes is observed in various types of cancers, such as breast, lung, prostate, colorectal, glioma, pancreatic, leukemia, prostate, gastric, ovarian, and chondrosarcoma. Here, DAXX is linked to cancer.